The antiinfective medicine market in Italy experienced significant fluctuations from 2013 through 2023. Notably, there was a sharp increase in sales in 2015, but subsequent years saw a general decline or slower growth, stabilizing around 2.65 billion Euros in 2023. This period included notable declines, particularly in 2017 and 2020, followed by marginal growth between 2021 and 2023. A Compound Annual Growth Rate (CAGR) of -1.91% over the last five years illustrates the recent stagnation.
Looking forward, the market is forecasted to grow moderately with a 5-year CAGR of 1.33%, reaching approximately 2.88 billion Euros by 2028. This points toward a gradual recovery and stabilization in sales post-2023. Key factors to watch include advancements in medical technology, shifts in disease prevalence, and policy changes influencing healthcare funding and pharmaceutical regulation.
Future trends to watch for:
- Innovations in antiinfective treatments that could boost sales.
- Regulatory changes impacting market dynamics.
- Emergence of antibiotic-resistant infections driving demand.
- Economic factors influencing healthcare spending and investment.
